– Application to label a less frequent dosing regimen at a dose of 2 mg/kg body weight administered every four weeks in adult patients with Fabry disease in European Union PARMA, Italy and CARMIEL, Israel , Dec. 9, 2024 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of the…
